Overview

The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer

Status:
Recruiting
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this pilot phase II trial is to identify the molecular and genetic mechanisms by which statins influence breast cancer cell proliferation. Simvastatin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and reduce the aggressiveness of breast cancer cells.
Phase:
Phase 2
Details
Lead Sponsor:
Michael Simon
Collaborator:
National Cancer Institute (NCI)
Treatments:
Simvastatin